Care.com, Inc. (NYSE:CRCM) issued an update on its FY18 earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.48. The company issued revenue guidance of $190 million, compared to the consensus revenue estimate of $189.73 million.Care.com also updated its Q4 guidance to $0.15-0.16 EPS.

Care.com (NYSE:CRCM) last announced its quarterly earnings results on Monday, October 30th. The information services provider reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.10. Care.com had a return on equity of 10.98% and a net margin of 3.66%. The company had revenue of $44.50 million during the quarter, compared to analyst estimates of $44.22 million. During the same quarter last year, the firm posted $0.02 earnings per share. The firm’s revenue was up 9.1% on a year-over-year basis.

A number of brokerages recently commented on CRCM. Zacks Investment Research lowered Care.com from a buy rating to a hold rating in a research note on Tuesday, October 10th. BidaskClub raised Care.com from a sell rating to a hold rating in a research note on Thursday, October 5th. Finally, Roth Capital set a $14.00 price objective on Care.com and gave the stock a hold rating in a report on Thursday, August 10th.

In other Care.com news, insider David Krupinski sold 3,326 shares of the stock in a transaction on Tuesday, September 12th. The stock was sold at an average price of $14.56, for a total value of $48,426.56. Following the completion of the transaction, the insider now owns 176,128 shares in the company, valued at $2,564,423.68. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, General Counsel Diane Musi sold 11,567 shares of the stock in a transaction on Wednesday, October 18th. The stock was sold at an average price of $15.81, for a total value of $182,874.27. Following the completion of the transaction, the general counsel now owns 35,328 shares of the company’s stock, valued at approximately $558,535.68. The disclosure for this sale can be found here. In the last quarter, insiders sold 56,353 shares of company stock valued at $888,182. 24.70% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This piece was posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2017/11/02/care-com-inc-crcm-updates-fy18-earnings-guidance.html.

A hedge fund recently raised its stake in Care.com stock. The Manufacturers Life Insurance Company boosted its position in Care.com, Inc. (NYSE:CRCM) by 47.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,801 shares of the information services provider’s stock after purchasing an additional 3,805 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Care.com were worth $179,000 at the end of the most recent quarter. 73.75% of the stock is owned by institutional investors and hedge funds.

About Care.com

Care.com, Inc is an online marketplace for finding and managing family care. As of December 31, 2016, the Company had 22.8 million members, including 12.9 million families and 9.9 million caregivers, spanning 19 countries. Its consumer matching solutions allow families to search for, qualify, vet, connect with and select caregivers.

Receive News & Ratings for Care.com Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Care.com Inc. and related companies with MarketBeat.com's FREE daily email newsletter.